Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation

Kardiologia Polska

Volumn 63, Issue 6, 2005, Pages 585-592

  Kosior, Dariusz A ^a,d   Woakowska Kapłon, Beata ^b,e   Jasik, Mariusz ^a   Kiliszek, Marek ^a,d   Rabczenko, Daniel ^c,f   Opolski, Grzegorz ^a,d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Municipal Hospital   (Poland)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

^d WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

^e wi tokrzyskie Centrum Kardiologiczne   (Poland)

^f Instytut Higieny W Warszawie   (Poland)

Author keywords

Amiodarone; Electrical cardioversion; Persistent atrial fibrillation

Indexed keywords

AMIODARONE; THYROTROPIN; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT; SINUS RHYTHM; THYROTROPIN BLOOD LEVEL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; INSTRUMENTATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 33746278130     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pritchett EL. Management of atrial fibrillation. N Engl J Med 1992; 326: 1264-71.
2. Levy S. Cardioversion of chronic atrial fibrillation-towards a more aggressive approach. Eur Heart J 2000; 21: 263.
3. Prystowsky EN. Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why? Am J Cardiol 2000; 86: 326-7.
4. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation 1980; 62: 212-7.
5. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
6. Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996; 156: 2585-92.
7. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41-6.
8. th ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. Chest 2001; 119: 194S-227S.
9. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA 1962; 182: 548-55.
10. Lown B, Kleiger R, Wolff G. The technique of cardioversion. Am Heart J 1964; 67: 282-4.
11. Lown B, Neuman J, Amarasingham R, et al. Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 1962; 10: 223-33.
12. Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996; 156: 2585-92.
13. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, et al. Pharmacological versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999; 84: 147R-51R.
14. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41-6.
15. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29: 469-89.
16. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Electrical cardioversion after amiodarone administration. Am Heart J 1992; 123: 1536-42.
17. Brodsky MA, Allen BJ, Walker CJ 3rd, et al. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987; 60: 572-5.
18. Gold RL, Haffajee CI, Charos G, et al. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986; 57: 124-7.
19. Kochiadakis GE, Igoumenidis NE, Solomou MC, et al. Efficacy of amiodarone for the termination of persistent atrial fibrillation. Am J Cardiol 1999; 83: 58-61.
20. Middlekauff HR, Wiener I, Stevenson WG. Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993; 72: 75F-81F.
21. Crijns HJ, Van Gelder IC, Van Gilst WH, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 1991; 68: 335-41.
22. Gosselink AT, Crijns HJ, Van Gelder IC, et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992; 267: 3289-93.
23. Opolski G, Stanisławska J, Górecki A, et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol 1997; 20: 337-40.
24. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-94.
25. Capucci A, Villani GQ, Aschieri D, et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000; 21: 66-73.
26. Gosselink ATM, Crijns HJGM, Hillege H, et al. Factors determining conversion of difficult-to-treat atrial fibrillation and flutter on oral amiodarone. JACC 1993, 21, 202A.
27. Singh BN. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol 1997; 20: 608-18.